-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
AbCellera Biologics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2019 to Q3 2025.
- AbCellera Biologics Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$57.1M, a 11.8% decline year-over-year.
- AbCellera Biologics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$172M, a 2.34% increase year-over-year.
- AbCellera Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$163M, a 11.2% decline from 2023.
- AbCellera Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$146M, a 192% decline from 2022.
- AbCellera Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $159M, a 3.29% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)